Department of Neurological Surgery, University of Florida, Gainesville, Florida.
J Neurosurg Spine. 2014 Oct;21(4):677-84. doi: 10.3171/2014.6.SPINE13447. Epub 2014 Aug 8.
Venous thromboembolism (VTE) represents a significant complication after spine surgery, with reported rates as high as 2%-4%. Published institutional practices for VTE prophylaxis are highly variable. In 2008, the authors implemented a departmental protocol for early VTE prophylaxis consisting of combined compressive devices and subcutaneous heparin initiated either preoperatively or on the same day of surgery. In this study, the authors compared the incidence of VTE in spine surgery patients before and after implementing this protocol.
An institutional review board-approved retrospective review of outcomes in patients undergoing spine surgery 2 years before protocol implementation (representing the preprotocol group) and of outcomes in patients treated 2 years thereafter (the postprotocol group) was conducted. Inclusion criteria were that patients were 18 years or older and had been admitted for 1 or more days. Before 2008 (preprotocol), VTE prophylaxis was variable and provider dependent without any uniform protocol. Since 2008 (postprotocol), a new VTE-prophylaxis protocol was administered, starting either preoperatively or on the same day of surgery and continuing throughout hospitalization. The new protocol consisted of 5000 U heparin administered subcutaneously 3 times daily, except in patients older than 75 years or weighing less than 50 kg, who received this dose twice daily. All patients also received sequential compression devices (SCDs). The incidence of VTE in the 2 protocol phases was identified by codes of the International Classification of Diseases, Ninth Revision (ICD-9) codes for deep vein thrombosis (DVT) and pulmonary embolus (PE). Bleeding complications arising from anticoagulation treatments were evaluated by the Current Procedural Terminology (CPT) code for postoperative epidural hematoma (EDH) requiring evacuation.
In total, 941 patients in the preprotocol group met the inclusion criteria: 25 had DVT (2.7%), 6 had PE (0.6%), and 6 had postoperative EDH (0.6%). In the postprotocol group, 992 patients met the criteria: 10 had DVT (1.0%), 5 had PE (0.5%), and 4 had postoperative EDH (0.4%). This reduction in DVT after the protocol's implementation was statistically significant (p = 0.009). Despite early aggressive prophylaxis, the incidence of postoperative EDH did not increase and compared favorably to the published literature.
At a high-volume tertiary center, an aggressive protocol for early VTE prophylaxis after spine surgery decreases VTE incidence without increasing morbidity.
静脉血栓栓塞症(VTE)是脊柱手术后的一种严重并发症,其发生率高达 2%-4%。发表的机构实践中 VTE 预防措施差异很大。2008 年,作者实施了一项早期 VTE 预防方案,该方案包括联合使用压迫装置和皮下肝素,术前或手术当天开始使用。在这项研究中,作者比较了实施该方案前后脊柱手术患者 VTE 的发生率。
对 2 年前(方案实施前,代表预方案组)和 2 年后(方案实施后,后方案组)接受脊柱手术的患者进行机构审查委员会批准的回顾性结果分析。纳入标准为患者年龄 18 岁或以上,并住院 1 天或以上。在 2008 年之前(预方案),VTE 预防措施是可变的,并且依赖于提供者,没有任何统一的方案。自 2008 年以来(后方案),采用了新的 VTE 预防方案,术前或手术当天开始,并在整个住院期间持续使用。新方案包括每天皮下注射 5000U 肝素 3 次,75 岁以上或体重不足 50 公斤的患者每天 2 次。所有患者还接受连续压迫装置(SCD)治疗。通过国际疾病分类,第九修订版(ICD-9)代码为深静脉血栓形成(DVT)和肺栓塞(PE)的代码识别 2 个方案阶段的 VTE 发生率。通过术后硬膜外血肿(EDH)需要清除的手术程序术语(CPT)代码评估抗凝治疗引起的出血并发症。
在预方案组中,共有 941 名患者符合纳入标准:25 例发生 DVT(2.7%),6 例发生 PE(0.6%),6 例发生术后 EDH(0.6%)。在后方案组中,992 名患者符合标准:10 例发生 DVT(1.0%),5 例发生 PE(0.5%),4 例发生术后 EDH(0.4%)。方案实施后 DVT 的减少具有统计学意义(p=0.009)。尽管早期积极预防,但术后 EDH 的发生率并没有增加,与文献报道的结果相比是有利的。
在高容量的三级中心,脊柱手术后早期积极的 VTE 预防方案可降低 VTE 的发生率,同时不增加发病率。